Daniel I. Swerdlow

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

Amand F. Schmidt, Daniel I. Swerdlow, Michael V. Holmes et al. · The Lancet Diabetes & Endocrinology · 2016 · 391 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes

Jon White, Daniel I. Swerdlow, David Preiss et al. · JAMA Cardiology · 2016 · 318 citations · Full text

Life Sciences, Biostatistics, Genetics +14

Mendelian randomization for studying the effects of perturbing drug targets

Dipender Gill, Marios K. Georgakis, Venexia Walker et al. · Wellcome Open Research · 2021 · 286 citations · Full text

Life Sciences, Genetics, Pharmacology +13

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

Steven E. Nissen, Kathy Wolski, Craig Balog et al. · JAMA · 2022 · 283 citations · Full text

Medicine, Cardiology, Pharmacology +16

Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis

Michael V. Holmes, Leslie A. Lange, Tom Palmer et al. · The American Journal of Human Genetics · 2014 · 232 citations · Full text

Public Health, Biostatistics, Genetics +14